hepatitis a (live) vaccine
Vaccineexperimental
Clinical trial activity
3 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
3
Earliest trial started Nov 1, 2011 (NCT02601040)
Timeline
No events for the selected filters.
Indications
Approved for
Studied for
Mechanism of action
- Hepatitis A virusImmunity, active
attenuated Hepatitis A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- attenuated hav vaccine, h2 strain
- attenuated hav vaccine, l-a-1 strain
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04612634 | Phase 4 | Nov 30, 2020 | Changchun Institute of Biological Products Co., Ltd., China National Biotec Group Co., Ltd, Government of China, Peking University |
| NCT01949857 | Phase 4 | Sep 1, 2013 | Chinese Academy of Medical Sciences, Government of China |
| NCT02601040 | Phase 4 | Nov 1, 2011 | Chinese Academy of Medical Sciences, Government of China |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 3 | 1 | 1 | 2011 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 2 | 1 | 1 | 2011 |
| Changchun Institute of Biological Products Co., Ltd. | For profit | 1 | 0 | 1 | 2020 |
| China National Biotec Group Co., Ltd | For profit | 1 | 1 | 1 | 2020 |
| Peking University | Academic/Hospital | 1 | 0 | 1 | 2020 |
5 organizations
Page 1 / 1